Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02417324 : International HIT-MED Registry (I-HIT-MED)
Phase
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- all patients with above mentioned diagnosis of all ages (except for ependymoma WHO I°,
pineal parenchymal tumour of intermediate differentiation and papillary tumour of the
pineal region, who will be registered only if primary diagnosis was before the 18th
birthday)

- any localisation of the primary tumour

- all clinical stages

- First diagnosis after 01.01.2012

- No inclusion into a prospective clinical trial for the same diagnosis, due to
non-eligibility, national lack of trial approval, or individual refusal of
participation.

- Written informed consent for data transfer and tumour sample submission according to
the laws of each participating country is necessary.

- National and/ or local ethical committee approval according to the laws of each
participating country is necessary.

Exclusion Criteria:

- Registration in another clinical trial for the same diagnosis (relapse is defined as a
second diagnosis).

- Lack of valid ethical committee approval.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02417324      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740